Paul Edward Kelly

RLMD

Paul Edward Kelly serves as Chief Operating Officer at Relmada Therapeutics, Inc. (RLMD). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$348.8K

Total Sells

2 trades

$478.9K

Net Position

Net Seller

$130.1K

Companies Traded

RLMD

Active Period

Mar 2021 – Nov 2025

5 total trades

Most Recent

Buy RLMD

Nov 5, 2025 · $198.0K

Paul Edward Kelly's Insider Trading at Relmada Therapeutics, Inc. (RLMD)

Buys

3 · $348.8K

Sells

2 · $478.9K

Total Shares Bought

315,000

Total Shares Sold

15,000

RLMD Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 5, 2025	Buy	90,000	$2.20	$198.0K	0
May 16, 2025	Buy	200,000	$0.43	$86.1K	0
Sep 11, 2024	Buy	25,000	$2.59	$64.8K	212,295
Apr 5, 2022	Sell	10,000	$30.04	$300.4K	187,295
Mar 11, 2021	Sell	5,000	$35.71	$178.6K	168,907

Related Insiders

Maged Shenouda

officer: Chief Financial Officer

RLMDBuy · Sep 11, 2026

TRAVERSA SERGIO

director, officer: Chief Executive Officer

RLMDBuy · Sep 11, 2026

Chuck Ence

CAO and COO

RLMDBuy · Nov 5, 2025

Explore More Insider Trading Data

RLMD Insider Trading Activity

View all insider trades at Relmada Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity